Market Place
Sourcing Support
Avalo Therapeutics, Inc. Announces Corporate Name Change from Cerecor Inc.
26 Aug 2021 //
GLOBENEWSWIRE
Cerecor Reports Second Quarter 2021 Financial Results
02 Aug 2021 //
GLOBENEWSWIRE
Cerecor Announces Drawdown of $10 Million Tranche under its Debt Financing
02 Aug 2021 //
GLOBENEWSWIRE
Cerecor Announces Drawdown of $10 Million Tranche
02 Aug 2021 //
GLOBENEWSWIRE
Cerecor Positive Initial Phase CERC-002 in Moderate to Severe Crohn`s Disease
26 Jul 2021 //
GLOBENEWSWIRE
FDA Grants Fast Track Designation to CERC-002
11 May 2021 //
GLOBENEWSWIRE
Cerecor Doses First Patient in a Phase 1b Proof-of-Concept Trial of CERC-007
05 May 2021 //
GLOBENEWSWIRE
Cerecor Announces New Worldwide License Agreement with Kyowa Kirin
29 Mar 2021 //
GLOBENEWSWIRE
Cerecor licenses cytokine storm antibody from Kyowa Kirin
29 Mar 2021 //
SCIENCEBOARD
Cerecor Reports 2020 Financial Results and Provides Business Updates
08 Mar 2021 //
GLOBENEWSWIRE
Cerecor Announces CERC-002 Significantly Reduced Respiratory Failure
02 Mar 2021 //
GLOBENEWSWIRE
Cerecor Announces Fast Track Designation for CERC-803 for the Treatment
02 Feb 2021 //
GLOBENEWSWIRE
Cerecor reports positive data from Covid-19 neutralising antibody trial
07 Jan 2021 //
CLINICALTRIALSARENA
Cerecor Announces FDA Acceptance of Investigational NDA for CERC-007
22 Dec 2020 //
GLOBENEWSWIRE
Cerecor Announces FDA Acceptance of Investigational NDA for CERC-007
22 Dec 2020 //
GLOBENEWSWIRE
Cerecor Announces First Patient Dosed in a Phase 1b Clinical Trial of CERC-007
16 Dec 2020 //
GLOBENEWSWIRE
Cerecor Announces FDA Acceptance of InvG lNDA for CERC-007
08 Dec 2020 //
GLOBENEWSWIRE
Cerecor Announces FDA Acceptance of Inda for CERC-803
01 Dec 2020 //
GLOBENEWSWIRE
Cerecor to Collaborate with Frontiers CDG Consortium on Pivotal Trial CERC-801
17 Nov 2020 //
GLOBENEWSWIRE
Cerecor Resumes Phase 1b Clinical Trial of CERC-002 for Treatment of Pediatric
26 Aug 2020 //
PRESS RELEASE
Cerecor Announces Peer-Reviewed Publication Highlighting the Role Inflammatory
13 Aug 2020 //
CERECOR
Cerecor Receives Orphan Drug Designation for CERC-006 in Lymphatic Malformations
03 Aug 2020 //
GLOBENEWSWIRE
Cerecor Announces FDA Clearance of IND for CERC-002 in COVID-19 Induced ARDS
28 May 2020 //
GLOBENEWSWIRE
Cerecor and Myriad Genetics Announce that Levels of LIGHT, a Novel Cytokine
26 May 2020 //
GLOBENEWSWIRE
Cerecor and Aevi Genomic Medicine Complete Merger
03 Feb 2020 //
GLOBENEWSWIRE
Cerecor to Acquire Aevi Genomic Medicine
05 Dec 2019 //
PR NEWSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.